/ Print /

LATEST

How Cigna reduced opioid use 12% in 12 monthsManaged Healthcare Executive (MHE) recently spoke with Cigna’s Chief Medical Officer for Behavioral Health Doug Nemecek, MD, about Cigna’s efforts, outcomes, and how it plans to reach its goal
How medical schools are responding to the opioid epidemicAs the opioid epidemic rages, up-and-coming physicians are seen as part of the solution. Here’s how medical schools are changing their training programs.
Nine new skills needed by health execsDo you have what it takes to succeed as a healthcare executive? Industry leaders weigh in.
Opinion: Three ways to maximize the benefits of physician assistantsHow Phoenix Children’s improved access, value and outcomes through a dedicated focus on advanced practice providers.
Opinion: Medicare for all: Imminent or pipe dream?As the nation debates the future of our healthcare system, one idea gaining attention is a “Medicare-for-all” single-payer national health insurance plan.
Four data analytics areas that promote cost savingsAnalytics is an integral component of healthcare no matter what Congress decides, according to one expert. Here are 4 areas of data analytics that health plans can develop that will promote future cost savings.
Medical marijuana update: Top 3 things health execs should knowHere’s what you need to know about medical marijuana laws, and what they mean for the healthcare system.
Controversy surrounds Exondys 51 approval: What to knowNew medicine for Duchenne muscular dystrophy raises questions. Here’s whose covering it and why.
Eight data analytics terms every healthcare executive should knowWith so much going on in health IT, it can be difficult to keep track of all the buzzwords. Here’s your quick and easy guide.
Brace for a barrage of biosimilarsThe next few years will see the healthcare industry bracing itself for new biosimilar products for a range of illnesses from oncology to rheumatoid arthritis.